MAPT and Alzheimer disease: Additionally, the Aβ misfolding biomarker showed also significant correlations with standard CSF biomarkers (Aβ42, Aβ42/40 ratio, total‐tau, phosphor‐tau) as already seen in our former published study on late stage AD.